Express Pharma

Share PURIFY, India’s premier Chromatography Purification Conclave is dedicated towards pushing the boundaries of discovery, process development, and large-scale manufacturing in the pharmaceutical and life sciences sectors. As the global pharmaceutical industry delves deeper into advanced separation techniques, PURIFY continues its mission as a pioneer platform for scientists, research leaders, and industry decision-makers looking to overcome everyday purification challenges.

Share Acrotech Biopharma, a biopharmaceutical company focused on developing and commercializing innovative proprietary medicines, announced the US launch of ADQUEY(difamilast 1%) ointment, a non-steroidal topical treatment for mild-to-moderate atopic dermatitis in adults and pediatric patients 2 years of age and older. Difamilast was originally discovered by Otsuka Pharmaceutical and licensed to Acrotech Biopharma for U.S. commercialization.

Express Pharma, first published as Express Pharma Pulse in 1994, is today India’s leading business fortnightly for the pharmaceutical industry. With the patronage of its readers, Express Pharma has grown to become the No.1 Business News Magazine for the pharmaceutical industry.

Share As pharma companies accelerate digital transformation, lab informatics is emerging as a strategic enabler of faster R&D, stronger data integrity, regulatory compliance, technology transfer and operational efficiency.

Share Zenex Animal Health India , one of India’s leading animal health companies backed by Multiples Alternate Asset Management, announced the acquisition of the companion animal business operating under the SAVAVET brand from SAVA Healthcare Limited (“SAVA Healthcare”). The acquisition marks Zenex’s third strategic acquisition since partnering with Multiples and represents another significant milestone in its journey to build one of India’s most comprehensive animal healthcare platforms.

Share Biodeal Pharmaceuticals, a leading Contract Development and Manufacturing Organisation (CDMO), has acquired a sterile injectable manufacturing facility in Paonta Sahib, Himachal Pradesh – one of the largest manufacturing facilities in the state – from Biological E.

Share For oral solid dosage manufacturers, validation should not be treated as a milestone that ends after a small set of successful qualification batches. A lifecycle approach connects process understanding, process performance qualification, continued process verification, change management and periodic review so that evidence of control is maintained throughout commercial manufacturing.

Share Linux Laboratories, one of India’s fastest-growing domestic formulations companies, has secured USD 70 million in equity capital from ChrysCapital and Tata Capital Healthcare Fund III (“TCHF III”). ChrysCapital has acquired a significant minority stake in Linux. The transaction comprises a combination of primary capital and secondary purchase and includes the full exit of Tata Capital Healthcare Fund II (“TCHF II”) at approximately 4x returns.

Share A 141-acre Pharma Park and a 200-acre Medicity are set to give Chhattisgarh a new impetus to healthcare services, investment and employment as it seeks to build a healthcare ecosystem. The two projects are designed to merge pharmaceutical manufacturing, medical education, research and healthcare services into an integrated ecosystem. The move will strengthen healthcare delivery while also creating new avenues for investment and employment in the state.

Share What will fuel the next round of growth, and how can companies stay ahead in this race? The combination of cost competitiveness and scale has brought India into the fold of the global pharma industry, but what keeps us here now is our ability to be consistent in maintaining the quality of our drugs and our maturity in handling regulations and developing products further up the value chain.